ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.

Saved in:
Bibliographic Details
Title: ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.
Authors: Wang L; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Dougherty U; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., He W; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Gao L; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Muefong C; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Sarkar R; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Du J; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Shergill A; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Lin H; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Department of Chemistry, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, USA., Bissonnette M; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Li YC; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Committee on Molecular Metabolism and Nutrition, The University of Chicago, Chicago, IL, USA.
Source: IScience [iScience] 2026 Jul 21; Vol. 29 (8), pp. 116860. Date of Electronic Publication: 2026 Jul 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42495523
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Dougherty+U%22">Dougherty U</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22He+W%22">He W</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Gao+L%22">Gao L</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Muefong+C%22">Muefong C</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Sarkar+R%22">Sarkar R</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Du+J%22">Du J</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Shergill+A%22">Shergill A</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Lin+H%22">Lin H</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Department of Chemistry, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Bissonnette+M%22">Bissonnette M</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Li+YC%22">Li YC</searchLink>; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Committee on Molecular Metabolism and Nutrition, The University of Chicago, Chicago, IL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2026 Jul 21; Vol. 29 (8), pp. 116860. <i>Date of Electronic Publication: </i>2026 Jul 21 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42495523
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.isci.2026.116860
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 116860
    Titles:
      – TitleFull: ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Dougherty U
      – PersonEntity:
          Name:
            NameFull: He W
      – PersonEntity:
          Name:
            NameFull: Gao L
      – PersonEntity:
          Name:
            NameFull: Muefong C
      – PersonEntity:
          Name:
            NameFull: Sarkar R
      – PersonEntity:
          Name:
            NameFull: Du J
      – PersonEntity:
          Name:
            NameFull: Shergill A
      – PersonEntity:
          Name:
            NameFull: Lin H
      – PersonEntity:
          Name:
            NameFull: Bissonnette M
      – PersonEntity:
          Name:
            NameFull: Li YC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 07
              Text: 2026 Jul 21
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2589-0042
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: IScience
              Type: main
ResultId 1